Smithfield Grain – FDA EIR, Aug 31, 2021

An FDA surveillance inspection of Smithfield Grain, located in Wilson, NC, was conducted from August 30-31, 2021. The inspection, carried out by the North Carolina Department of Agriculture and Consumer Services, aimed to assess the company's compliance with regulations governing animal food. The primary regulatory frameworks reviewed included 21 CFR Part 507, which outlines preventive controls for animal food, and 21 CFR Part 589, pertaining to bovine spongiform encephalopathy (BSE) requirements for animal feed. Key aspects examined during the inspection included raw material handling, manufacturing processes, product labeling, and employee training programs.

The inspection concluded with a "No Action Indicated (NAI)" classification, signifying that no significant objectionable findings were reported. Minor observations were discussed with company management during the inspection, but no formal regulatory actions were required. This outcome contrasts with a previous inspection in August 2019, where an issue regarding insufficient employee training in animal food hygiene and safety had been identified. For the 2021 inspection, no formal violations or required actions were documented by the regulatory authorities.